evo真人视讯

Professor Shi Yuanyuan, Chairman of Shenzhen Cell Valley, was invited to attend the Asia Healthcare Trends and Innovation Conference International Forum

Date:11-23  Hits:  Belong to:Corporate News


On November 21, the Asia Healthcare Trends and Innovation International Forum successfully opened in Shanghai.Co-hosted by YPO China Healthcare Business Network and YPO China Business Summit, the forum aims to bring together business leaders, investors, service providers, international researchers, and medical experts in the global healthcare sector to examine the latest trends in healthcare innovation and investment, explore cooperation opportunities in the international healthcare field, and showcase various opportunities for investors and project decision-makers. Professor Shi Yuanyuan, Chairman of Shenzhen Cell Valley, was invited to attend and participated in a professional roundtable discussion.

During the professional roundtable discussion, Professor Shi Yuanyuan engaged in an in-depth exploration with domain experts on the theme 'The Future of Biotechnology, Advanced Therapeutic Medicinal Products (ATMP), and Precision Medicine—How Biotechnology and Precision Medicine Are Transforming the Landscape of Disease Treatment and Its Future Development.'

During the seminar, experts focused on the rapid development of precision medicine, particularly how advancements in molecular biology are redefining the classification of human diseases and triggering a healthcare revolution. Additionally, Professor Shi Yuanyuan shared insights on the progress of Shenzhen Cell Valley in advancing its international strategic layout, and jointly explored the prospects and business opportunities in Asia's healthcare industry.


This forum, focusing on healthcare-related fields, provided participants with a multidimensional exchange platform. By participating in this forum, Shenzhen Cell Valley showcased its significant progress in advancing its international strategic layout, particularly in innovation and industrialization within the cell therapy sector.The successful hosting of the forum not only facilitated communication and collaboration within the industry but also provided new growth momentum for the development of the healthcare industry both domestically and globally. It offered an important platform and opportunities for future cooperation and development in the healthcare sector.



take a group photo to mark the occasion




图片

The Young Presidents 'Organization (YPO), a non-profit and non-political initiative founded in the 1950s, is dedicated to empowering members to become better leaders through education and intellectual exchange, thereby influencing employees, clients, and society at large. As the world's largest CEO organization, YPO boasts over 30,000 members globally. These members collectively manage corporate sales exceeding $7 trillion, enabling them to rank among the world's top three economies. In many countries, member companies hold dominant market positions.

 

The China Chamber of Commerce (Doing Business with China Network) is a branch of YPO, comprising thousands of members doing business with China. Since 2011, it has held an annual summit in hot cities across China, known as the YPO China Business Summit (China Business Summit, abbreviated as CBS). Each summit brings together members from 20 to 30 countries, aiming to understand changes in China, learn from successful experiences in doing business with China, and connect with partners who can assist in business. The summit's keynote speeches cover current hot topics and industries, inviting seasoned government and business professionals to share insights. Since the Shenzhen Summit, the event has specially included an open session for local entrepreneurs and government officials, fostering exchanges between YPO members and the local community.






About Us
Scan to follow our latest newsScan to follow our latest news
Contact Us
400-800-1266

Working hours: Monday to Friday, 9:00-18:00

Contact:Ms. Lai

Email:laijiaqi@rodael.com

Address:No. 1, Rongtian Road, Jinsha Community, Kengzi Street, Pingshan District, Shenzhen, China (Hepure Biomedical Ecological Park)

Bottom Navigation
Shenzhen Cell Valley Biopharmaceutical Co., Ltd.​​ is a comprehensive one-stop outsourcing service provider in China focused on the cell and gene therapy industry. It is also one of the first CRO/CDMO companies in the country to possess GMP industrial production capabilities for clinical-grade retroviral vectors . The company is a major public technical service platform construction project for CRO/CDMO in Shenzhen and is included among the city's latest announced "20+8" strategic emerging industry projects.Shenzhen Cell Valley has the capability for standardized and industrialized production of GMP-grade cell products such as CAR-T cells. Its primary production lines include those for various cell products like CAR-T, CAR-NK, CAR-M, γδT, TIL, and TCR-T. Additionally, the company operates production lines for various viral vectors, including RVV, LVV, non-viral vectors, and AAV, as well as for cellular raw materials used in producing therapeutics such as exosomes, genetically engineered antibodies, cytokines, oncolytic viruses, and vaccines.
 Copyright 粤ICP备2024168379号 互联网药品信息服务资格证书:(粤)-非经营性-2022-0426  Technical Support:YouDian Software